why choose us

First received: September 18, 2023

Clinical Trial: A Study of Carbon-14-Labelled [14C] LY3556050 in Healthy Male Participants

Study Status: Completed

Recruit Status: RECRUITING

Condition: Healthy

Study Type: INTERVENTIONAL


Official Title: Disposition of [14C]-LY3556050 Following Oral Administration in Healthy Male Participants

Brief Summary: The main purpose of this study is to evaluate how much of the study drug (LY3556050), administered as a single dose that has the radioactive substance 14C incorporated into it, passes from blood into urine, feces and expired air in healthy male participants.The study will also measure how much of the study drug gets into the bloodstream, how its broken down, and how long it takes the body to get rid of it.The study will last up to approximately 58 days including the screening period.

Read more